Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis

[1]  M. Saad,et al.  Liraglutide modulates gut microbiota and reduces NAFLD in obese mice. , 2018, The Journal of nutritional biochemistry.

[2]  Patrice D Cani,et al.  The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice , 2018, Diabetologia.

[3]  Yingli Lu,et al.  A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota , 2018, Front. Endocrinol..

[4]  H. Berthoud,et al.  Harnessing Gut Microbes for Mental Health: Getting From Here to There , 2018, Biological Psychiatry.

[5]  T. Z. Waise,et al.  Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway. , 2018, Cell metabolism.

[6]  Defa Li,et al.  Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice , 2017, BMC Biology.

[7]  Shaodong Guo,et al.  DPP-4 Inhibitors Improve Diabetic Wound Healing via Direct and Indirect Promotion of Epithelial-Mesenchymal Transition and Reduction of Scarring , 2017, Diabetes.

[8]  Xun Xu,et al.  Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment , 2017, Nature Communications.

[9]  G. Mithieux,et al.  Gut-Brain Glucose Signaling in Energy Homeostasis. , 2017, Cell metabolism.

[10]  Jing Shang,et al.  Simvastatin and Bezafibrate ameliorate Emotional disorder Induced by High fat diet in C57BL/6 mice , 2017, Scientific Reports.

[11]  David Torrents,et al.  Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug , 2017, Nature Medicine.

[12]  R. Burcelin,et al.  A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism. , 2017, Cell metabolism.

[13]  M. Laakso,et al.  Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort , 2017, Genome Biology.

[14]  J. Suez,et al.  Personalized microbiome‐based approaches to metabolic syndrome management and prevention , 2017, Journal of diabetes.

[15]  R. Dempsey,et al.  Regulation of Dipeptidyl Peptidase IV in the Post-stroke Rat Brain and In Vitro Ischemia: Implications for Chemokine-Mediated Neural Progenitor Cell Migration and Angiogenesis , 2016, Molecular Neurobiology.

[16]  S. Lynch,et al.  The Human Intestinal Microbiome in Health and Disease. , 2016, The New England journal of medicine.

[17]  D. Wishart,et al.  Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome , 2016, Diabetes.

[18]  B. Feng,et al.  Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment , 2016, Scientific Reports.

[19]  B. Feng,et al.  Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal Study , 2016, Journal of diabetes research.

[20]  E. Bae.  DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control , 2016, Archives of pharmacal research.

[21]  Jinqiao Qian,et al.  Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome , 2016, BMJ Open Diabetes Research and Care.

[22]  F. Bäckhed,et al.  Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis. , 2016, Cell metabolism.

[23]  F. Bäckhed,et al.  From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites , 2016, Cell.

[24]  J Licinio,et al.  Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism , 2016, Molecular Psychiatry.

[25]  R. Xavier,et al.  Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease , 2016, Science.

[26]  K. Petersen,et al.  Acetate mediates a microbiome-brain-β cell axis promoting metabolic syndrome , 2016, Nature.

[27]  Xiaocui Wang,et al.  NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis , 2016, Science Translational Medicine.

[28]  Huawei Zeng,et al.  Colonic Inflammation Accompanies An Increase of β‐Catenin Signaling and Lachnospiraceae/Streptococcaceae in the Hind Gut of High‐Fat Diet‐Fed Mice , 2016, The Journal of nutritional biochemistry.

[29]  Jing Li,et al.  Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus , 2015, Journal of diabetes.

[30]  Irl B Hirsch,et al.  American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[31]  J. Seong,et al.  Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon‐like peptide 1 in diet‐induced obesity , 2015, The FASEB Journal.

[32]  E. Levy,et al.  A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice , 2014, Gut.

[33]  Patrice D Cani,et al.  Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice , 2014, mBio.

[34]  H. Flint,et al.  Phylogenetic distribution of three pathways for propionate production within the human gut microbiota , 2014, The ISME Journal.

[35]  P. François,et al.  Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity , 2014, The ISME Journal.

[36]  D. Antonopoulos,et al.  Exercise Prevents Weight Gain and Alters the Gut Microbiota in a Mouse Model of High Fat Diet-Induced Obesity , 2014, PloS one.

[37]  F. Bäckhed,et al.  Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits , 2014, Cell.

[38]  Liping Zhao,et al.  A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome , 2013, FEMS microbiology ecology.

[39]  A. Mansur,et al.  Circulating Dipeptidyl Peptidase IV Activity Correlates With Cardiac Dysfunction in Human and Experimental Heart Failure , 2013, Circulation. Heart failure.

[40]  Na-Ri Shin,et al.  An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice , 2013, Gut.

[41]  Fredrik H. Karlsson,et al.  Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.

[42]  Dong-Hyun Kim,et al.  High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway , 2012, PloS one.

[43]  Susan Cheng,et al.  Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans , 2012, Circulation.

[44]  S. Rajagopalan,et al.  Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis , 2011, Circulation.

[45]  Michael A Fischbach,et al.  Eating for two: how metabolism establishes interspecies interactions in the gut. , 2011, Cell host & microbe.

[46]  Jacques Schrenzel,et al.  Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice , 2011, Diabetes.

[47]  Jose U. Scher,et al.  The microbiome and rheumatoid arthritis , 2011, Nature Reviews Rheumatology.

[48]  J. Clemente,et al.  Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans , 2011, Science.

[49]  J. Tap,et al.  Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss , 2010, Diabetes.

[50]  R. Knight,et al.  The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.

[51]  Rob Knight,et al.  High-fat diet determines the composition of the murine gut microbiome independently of obesity. , 2009, Gastroenterology.

[52]  D. Doudet,et al.  Inhibition of Dipeptidyl Peptidase IV With Sitagliptin (MK0431) Prolongs Islet Graft Survival in Streptozotocin-Induced Diabetic Mice , 2008, Diabetes.

[53]  C. Knauf,et al.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.

[54]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[55]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[56]  D. Drucker,et al.  The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes , 2006, The Lancet.

[57]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[58]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[60]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[61]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Molero,et al.  Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats , 2001, Diabetes, obesity & metabolism.

[63]  H. Meltzer,et al.  Treatment with interferon-alpha (IFNα) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFNα-induced depressive and anxiety symptoms and immune activation , 2001, Molecular Psychiatry.

[64]  P. Clifton,et al.  Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. , 2001, Physiological reviews.

[65]  J. Holst,et al.  Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. , 1998, Diabetes.

[66]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[67]  C. Cheeseman,et al.  Inhibition of glucose absorption in the rat jejunum: a novel action of alpha-D-glucosidase inhibitors. , 1997, Gastroenterology.

[68]  H. Dijkman,et al.  Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[69]  M. Wolin,et al.  Propionate Formation from Cellulose and Soluble Sugars by Combined Cultures of Bacteroides succinogenes and Selenomonas ruminantium , 1973 .